País: Jordania
Idioma: inglés
Fuente: JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)
Lidocaine 40 mg, Tribenoside 400 mg
مستودع ادوية السختيان - Sukhtian Group
C05AX05
Lidocaine 40 mg, Tribenoside 400 mg
40 mg, 400 mg
10
Delpharm Huningue S.A.S (فرنسا)
3.39 :سعر الجمهور + الضريبة
PROCTO-GLYVENOL® Cream and Suppository COMPOSITION : Active ingredients: tribenoside, lidocaine/ lidocaine hydrochloride. Cream: Preservatives: methyl (E218) and propyl (E216) parahydroxy- benzoate, other excipients. Pharmaceutical forms and quantity of active ingredient per unit 1 suppository (2 g) contains 400 mg of tribenoside and 40 mg of lidocaine. The suppositories are yellowish-white and torpedo- shaped. 100g of cream contain 5% tribenoside and 2.12% lidocaine hydrochloride. 1 g of cream contains 50 mg of tribenoside and 21.2 mg of lidocaine hydrochloride. The cream is white and homogenous. INDICATIONS/POSSIBLE USES: Local treatment of external and internal haemorrhoids. POSOLOGY/METHOD OF ADMINISTRATION Adults: During the acute phase of the disorder, apply the cream or suppository morning and evening; subsequently, reduce to one application of cream or one suppository a day. 30g of cream (1 tube) are enough for approximately 20-30 applications. Avoid contact with the eyes. Intended for adult use only; not suitable for children. CONTRAINDICATIONS Hypersensitivity to the active ingredients or excipients, according to composition. WARNINGS AND PRECAUTIONS: Where there is bleeding in the anal area or where faecal blood is suspected or in the onset of other unusual symptoms, a medical examination with a view to diagnosis is advised. Where symptoms appear for the first time, self-medication should not last longer than 2 weeks. Repeat treatment should only take place following diagnosis confirmed by a doctor. Procto-Glyvenol should be used with caution in patients with severely impaired liver function. There is no clinical experience in children. Procto-Glyvenol cream contains cetyl alcohol, which may lead to local skin reactions (e.g. contact dermatitis). The cream also contains methyl and propyl parahydroxybenzoate; these substances may trigger allergic reactions (possibly delayed). INTERACTIONS No interaction studies have been performed. PREGNANCY/BREASTFEEDING: There is not enough data concerning use in pre Leer el documento completo